$Corvus Pharmaceuticals (CRVS.US)$ Corvus Pharmaceuticals Announces Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Data from lowest dose level cohorts demonstrate a favorable safety and efficacy profile
Data includes complete results from cohort 1 and initial results from cohort 2
Early exercise of common stock warrants from stockholder generates cash proceeds of approximately $12.7 million
Company to host conference call and webca...

NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
$KULR Technology (KULR.US)$  PR 12/17: Signs Service Agreement to Launch KULR ONE Space Battery. COH $13.4M good for 9 months✅
$Wearable Devices (WLDS.US)$ PR 12/17:...

$Tonix Pharmaceuticals (TNXP.US)$ take profits to $NewGenIvf (NIVF.US)$  ticking time bomb

$Destiny Tech100 (DXYZ.US)$ I feel like it can go up this afternoon.

$Archer Aviation (ACHR.US)$ its back up!!!

$Archer Aviation (ACHR.US)$ will hit 9?

$Ocean Power Technologies (OPTT.US)$ .434

$NVIDIA (NVDA.US)$ bears are fanning unusual option activities costing hundreds of millions of dollars as the stock price fluctuates less than a day after the AI chip giant reported its fiscal third quarter financial results.
The biggest of those unusual trades involved the sale of call options that give the holders the right to buy 12.3 million Nvidia shares at $135 by Dec. 20, exchange data compiled by moomoo showed. The ...

$Taiwan Semiconductor (TSM.US)$ lets go 198 today